HowShorted

How shorted is Vor Biopharma Inc.?

More shorted than 91% of the 2,877 ranked US companies

14.85%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.07
5 reports (~10 weeks)
+5.44
Aggregate net short position time series for Vor Biopharma Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202614.85%−0.07
15 Jul 202614.92%−0.93
30 Jun 202615.85%+3.67
15 Jun 202612.18%+2.32
29 May 20269.86%+0.45
15 May 20269.41%−0.74
30 Apr 202610.15%+0.51
15 Apr 20269.64%−2.00
31 Mar 202611.64%+9.47
28 Nov 20252.17%−0.66
14 Nov 20252.83%−14.56
15 Sep 202517.39%+1.77
29 Aug 202515.62%+1.08
15 Aug 202514.54%−0.33
31 Jul 202514.87%–

Frequently asked questions

How shorted is Vor Biopharma Inc. right now?
14.85% of Vor Biopharma Inc.'s (VOR) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.